What are the clinical manifestations of acute pancreatitis in an adult without prior pancreatic disease?

Clinical Manifestations of Acute Pancreatitis

Acute pancreatitis presents with at least two of three cardinal features: acute onset of persistent, severe epigastric pain often radiating to the back; serum lipase or amylase at least three times the upper limit of normal; and characteristic findings on cross-sectional imaging. 1

Primary Clinical Presentation

Pain Characteristics:

• Acute onset of persistent, severe epigastric pain is the hallmark symptom, frequently radiating to the back 1
• Pain is typically severe enough to prompt emergency department presentation 2
• Important caveat: Painless acute pancreatitis exists but is rare and associated with higher mortality due to delayed diagnosis 3

Biochemical Evidence:

• Serum lipase is the preferred diagnostic marker over amylase, remaining elevated longer (8-14 days vs. 3-7 days) 1
• Diagnostic threshold: ≥3 times the upper limit of normal for either enzyme 1, 4
• Lipase rises within 4-8 hours and peaks at 24 hours 1
• Amylase rises within 6-24 hours and peaks at 48 hours 1

Severity-Based Clinical Manifestations

Mild Acute Pancreatitis (80-85% of cases):

• Absence of organ failure 1
• No local or systemic complications 1
• Self-limited course, typically resolving within the first week 1
• Mortality <1-3% 1

Moderately Severe Acute Pancreatitis:

• Transient organ failure (<48 hours) 1
• Local complications (peripancreatic fluid collections) 1
• Exacerbation of comorbid diseases 1

Severe Acute Pancreatitis (20-30% of cases):

• Persistent organ failure (>48 hours) affecting cardiovascular, respiratory, and/or renal systems 1
• Mortality rate 13-35% 1
• Highest mortality (35.2%) occurs with infected necrosis plus organ failure 1

Systemic Manifestations and Complications

Early Phase (First Week):

• Multiple organ failure from inflammatory mediators and activated leukocytes 5
• Hypotension and shock from vasoactive peptides (bradykinin, myocardial depressant factor) 6
• Adult respiratory distress syndrome from enzyme digestion of pulmonary surfactant 6
• Hypocalcemia (calcium <8.5 mg/dL indicates severity) 6
• Hyperglycemia or hypoglycemia 6, 3

Late Phase (After Second Week):

• Local and systemic septic complications become dominant 5
• Around 80% of deaths are caused by septic complications 5
• Infection of pancreatic necrosis occurs in 30-40% of necrotizing pancreatitis 5

Additional Systemic Manifestations:

• Coagulation abnormalities from activated trypsin 6
• Renal dysfunction 6
• Rare: visual disturbances from retinal vessel thrombosis, subcutaneous fat necrosis, arthralgia, pancreatic encephalopathy 6

Imaging Findings

Ultrasound (Initial Assessment):

• Should be obtained at admission to identify gallstones or biliary obstruction 1
• May show pancreatic enlargement 1

CT Findings (After 72 Hours):

• Indicated for predicted severe disease (APACHE II >8) or organ failure in first 72 hours 1
• Normal pancreas to pancreatic enlargement in mild cases 1, 7
• Pancreatic inflammation and peripancreatic fat stranding 1, 7
• Fluid collections (single or multiple) 1
• Pancreatic necrosis (non-enhancement of pancreatic parenchyma) 1
• Phlegmonous changes in 11% of edematous pancreatitis, 89% of necrotizing pancreatitis 7
• Pleural effusion (independent risk factor for complicated course) 8

Prognostic Laboratory Parameters at Presentation

High-Risk Indicators:

• Hematocrit >44% (independent risk factor for pancreatic necrosis) 1
• Urea >20 mg/dL (independent predictor of mortality) 1
• C-reactive protein ≥150 mg/L at 48-72 hours (prognostic for severe disease) 1
• Procalcitonin elevation (most sensitive for pancreatic infection detection) 1
• Systemic inflammatory response syndrome criteria (independent risk factor for complications) 8

Common Pitfalls

• Do not wait for imaging if two other diagnostic criteria are met – diagnosis requires only 2 of 3 criteria 1
• Do not dismiss cases without typical pain – painless pancreatitis exists and carries worse prognosis due to delayed recognition 3
• Do not rely solely on amylase – lipase is more specific and remains elevated longer 1
• CT findings may persist for months after clinical resolution, especially phlegmonous changes 7